Synchronization of Dendritic Cell Activation and Antigen Exposure Is Required for the Induction of Th1/Th17 Responses

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Immunology

• Publication date

  2012-05-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.4049/jimmunol.1103183PMID 22504654
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog.

  2012cited by this paper
• Comparison of the depot effect and immunogenicity of liposomes based on dimethyldioctadecylammonium (DDA), 3β-[N-(N',N'-Dimethylaminoethane)carbomyl] cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium propane (DOTAP): prolonged liposome retention mediates stronger Th1 responses.

  2011cited by this paper
• The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ

  2011cited by this paper
• Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets.

  2011cited by this paper
• Immunity by formulation design: induction of high CD8+ T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion method.

  2011cited by this paper
• Immunological mechanisms of vaccination

  2011cited by this paper
• Adjuvant Properties of Cytosine-Phosphate-Guanosine Oligodeoxynucleotide in Combination with Various Polycations in an Ovalbumin-Vaccine Model

  2011cited by this paper
• The regulation and role of T follicular helper cells in immunity

  2011cited by this paper
• Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes.

  2011cited by this paper
• Similar inflammatory DC maturation signatures induced by TNF or Trypanosoma brucei antigens instruct default Th2‐cell responses

  2011cited by this paper
• Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers.

  2010cited by this paper
• Unmet needs in modern vaccinology: adjuvants to improve the immune response.

  2010cited by this paper
• Programming dendritic cells to induce TH2 and tolerogenic responses

  2010cited by this paper
• CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells

  2010cited by this paper
• From skin dendritic cells to a simplified classification of human and mouse dendritic cell subsets

  2010cited by this paper
• Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response.

  2010cited by this paper
• Designing vaccines based on biology of human dendritic cell subsets.

  2010cited by this paper
• Correlates of Protection Induced by Vaccination

  2010cited by this paper
• Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response.

  2010cited by this paper
• Homeodomain only protein is required for the function of induced regulatory T cells in dendritic cell-mediated peripheral T cell unresponsiveness

  2010cited by this paper
• Effector T cell plasticity: flexibility in the face of changing circumstances

  2010cited by this paper
• CD44 regulates survival and memory development in Th1 cells.

  2010cited by this paper
• Vaccine adjuvants: putting innate immunity to work.

  2010cited by this paper
• Skin-draining lymph nodes contain dermis-derived CD103(-) dendritic cells that constitutively produce retinoic acid and induce Foxp3(+) regulatory T cells.

  2010cited by this paper
• Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response.

  2009cited by this paper
• A Liposome-Based Mycobacterial Vaccine Induces Potent Adult and Neonatal Multifunctional T Cells through the Exquisite Targeting of Dendritic Cells

  2009influential reference
• Inflammatory signals in dendritic cell activation and the induction of adaptive immunity

  2009cited by this paper
• Relationship between tightness of binding and immunogenicity in an aluminum-containing adjuvant-adsorbed hepatitis B vaccine.

  2009cited by this paper
• AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity1

  2009cited by this paper
• MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis

  2009cited by this paper
• Galectin‐1 functions as a Th2 cytokine that selectively induces Th1 apoptosis and promotes Th2 function

  2008cited by this paper
• Selective delivery of β cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice

  2008cited by this paper
• Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.

  2008cited by this paper
• Protective anti‐mycobacterial T cell responses through exquisite in vivo activation of vaccine‐targeted dendritic cells

  2008cited by this paper
• Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements

  2008cited by this paper
• Differential Antigen Processing by Dendritic Cell Subsets in Vivo

  2007cited by this paper
• Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity.

  2007cited by this paper
• TLR9 Signaling in B Cells Determines Class Switch Recombination to IgG2a

  2007cited by this paper
• The perfect mix: recent progress in adjuvant research

  2007cited by this paper
• The role of B cells in the induction of peripheral T cell tolerance

  2007cited by this paper
• Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants.

  2007cited by this paper
• The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes

  2007cited by this paper
• Formulation of vaccines containing CpG oligonucleotides and alum.

  2007cited by this paper
• Granzyme B is critical for T cell receptor-induced cell death of type 2 helper T cells.

  2006cited by this paper
• Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31.

  2006cited by this paper
• Intussusception and rotavirus vaccines.

  2006cited by this paper
• Toll-dependent selection of microbial antigens for presentation by dendritic cells

  2006cited by this paper
• Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function

  2005cited by this paper
• Inducing and expanding regulatory T cell populations by foreign antigen

  2005cited by this paper
• Granzyme B, a New Player in Activation-Induced Cell Death, Is Down-Regulated by Vasoactive Intestinal Peptide in Th2 but Not Th1 Effectors1

  2005cited by this paper
• IL-4 utilizes an alternative receptor to drive apoptosis of Th1 cells and skews neonatal immunity toward Th2.

  2004cited by this paper
• In Situ Analysis Reveals Physical Interactions Between CD11b+ Dendritic Cells and Antigen-Specific CD4 T Cells After Subcutaneous Injection of Antigen1

  2002cited by this paper
• Poly-L-arginine synergizes with oligodeoxynucleotides containing CpG-motifs (CpG-ODN) for enhanced and prolonged immune responses and prevents the CpG-ODN-induced systemic release of pro-inflammatory cytokines.

  2002cited by this paper
• Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance

  2002cited by this paper
• Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance

  2002cited by this paper
• Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo

  2001cited by this paper
• IFN-gamma-independent IgG2a production in mice infected with viruses and parasites.

  2000cited by this paper
• Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity.

  2000cited by this paper
• IFN-γ-independent IgG2a production in mice infected with viruses and parasites

  2000cited by this paper
• Peptide dose, affinity, and time of differentiation can contribute to the Th1/Th2 cytokine balance.

  1999cited by this paper
• Unequal Death in T Helper Cell (Th)1 and Th2 Effectors: Th1, but not Th2, Effectors Undergo Rapid Fas/FasL-mediated Apoptosis

  1997cited by this paper
• Immune deviation: A historical perspective *

  1996cited by this paper
• Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2‐biased pattern which persists after adult boosting

  1996cited by this paper
• B cells turn off virgin but not memory T cells.

  1992cited by this paper
• Selective and specific inhibition of 24 hour skin reactions in the guinea-pig. I. Immune deviation: description of the phenomenon and the effect of splenectomy.

  1965cited by this paper
• Brief Definitive Report a Retinoic Acid–dependent Checkpoint in the Development of Cd4 + T Cell–mediated Immunity

  year unknowncited by this paper

• Adsorption of antigen to polymeric nanoparticles enhances cytotoxic T‐cell responses and anti‐tumor immunity by targeting conventional type 1 dendritic cells

  2025cites this paper
• Subunit antigen delivery: emulsion and liposomal adjuvants for next-generation vaccines

  2025influential citation
• Immunogenicity of a Recombinant Zoster Vaccine (gE/BFA01) in Mice

  2025cites this paper
• Improved biodistribution and enhanced immune response of subunit vaccine using a nanostructure formed by self-assembly of ascorbyl palmitate.

  2024cites this paper
• Adjuvanted Modified Bacterial Antigens for Single-Dose Vaccines

  2024cites this paper
• Vaccination with Mincle agonist UM-1098 and mycobacterial antigens induces protective Th1 and Th17 responses

  2024cites this paper
• New-age vaccine adjuvants, their development, and future perspective

  2023cites this paper
• Method of manufacturing CAF®09 liposomes affect immune responses induced by adjuvanted subunit proteins.

  2023cites this paper
• Enhancing TB Vaccine Efficacy: Current Progress on Vaccines, Adjuvants and Immunization Strategies

  2023cites this paper
• Immune responses following neonatal vaccination with conserved F4 fragment of VtaA proteins from virulent Glaesserella parasuis adjuvanted with CAF®01 or CDA

  2023cites this paper
• Pulmonary Administration of the Liposome-Based Adjuvant CAF01: Effect of Surface Charge on Mucosal Adjuvant Function.

  2022cites this paper
• Adsorption of protein antigen to the cationic liposome adjuvant CAF®01 is required for induction of Th1 and Th17 responses but not for antibody induction

  2021cites this paper
• Th1/Th17 T cell Tissue-Resident Immunity Increases Protection, But Is Not Required in a Vaccine Strategy Against Genital Infection With Chlamydia trachomatis

  2021cites this paper
• Co-Adsorption of Synthetic Mincle Agonists and Antigen to Silica Nanoparticles for Enhanced Vaccine Activity: A Formulation Approach to Co-Delivery.

  2020cites this paper
• Different doses of ovalbumin exposure on dendritic cells determine their genetic/epigenetic regulation and T cell differentiation

  2020cites this paper
• Rational design of adjuvants for subunit vaccines: The format of cationic adjuvants affects the induction of antigen-specific antibody responses.

  2020cites this paper
• Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines

  2020cites this paper
• Intrapulmonary (i.pulmon.) Pull Immunization With the Tuberculosis Subunit Vaccine Candidate H56/CAF01 After Intramuscular (i.m.) Priming Elicits a Distinct Innate Myeloid Response and Activation of Antigen-Presenting Cells Than i.m. or i.pulmon. Prime Immunization Alone

  2020cites this paper
• Immune Recognition of Pathogen-Derived Glycolipids Through Mincle.

  2020cites this paper
• Species-Specific Structural Requirements of Alpha-Branched Trehalose Diester Mincle Agonists

  2019cites this paper
• Neonatal vaccine effectiveness and the role of adjuvants

  2019cites this paper
• Scale-independent microfluidic production of cationic liposomal adjuvants and development of enhanced lymphatic targeting strategies.

  2019cites this paper
• Hussain, Mohammed Jubair and Wilkinson, Alexander and Bramwell, Vincent W. and Christensen, Dennis and Perrie, Yvonne (2014) Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl-sn-glycero-3-

  2018cites this paper
• Dual-Isotope SPECT/CT Imaging of the Tuberculosis Subunit Vaccine H56/CAF01: Induction of Strong Systemic and Mucosal IgA and T-Cell Responses in Mice Upon Subcutaneous Prime and Intrapulmonary Boost Immunization

  2018cites this paper
• Immunocorrelates of CAF family adjuvants.

  2018cites this paper
• Subpopulation Structure of IFNγ-Producing T Lymphocytes in Patients with Pulmonary Tuberculosis

  2018cites this paper
• Immunology and efficacy of MF59-adjuvanted vaccines

  2018cites this paper
• Lipid conjugation of TLR7 agonist Resiquimod ensures co‐delivery with the liposomal Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation compared to non‐conjugated Resiquimod+CAF01

  2018cites this paper
• Spray dried cubosomes with ovalbumin and Quil‐A as a nanoparticulate dry powder vaccine formulation

  2018cites this paper
• Overcoming the Neonatal Limitations of Inducing Germinal Centers through Liposome-Based Adjuvants Including C-Type Lectin Agonists Trehalose Dibehenate or Curdlan

  2018cites this paper
• Poloxamer 407‐chitosan grafted thermoresponsive hydrogels achieve synchronous and sustained release of antigen and adjuvant from single‐shot vaccines

  2018cites this paper
• Lipid conjugation of TLR7 agonist Resiquimod ensures co-delivery with the liposomal 1 Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation compared to non-conjugated Resiquimod+CAF01.

  2018cites this paper
• Lipid conjugation of TLR 7 agonist Resiquimod ensures co-delivery with the liposomal Cationic Adjuvant Formulation 01 ( CAF 01 ) but does not enhance immunopotentiation compared to non-conjugated Resiquimod + CAF 01

  2018cites this paper
• pH responsive nanoparticles as versatile carriers for cancer chemotherapy and vaccination

  2018cites this paper
• Rational Design and In Vivo Characterization of Vaccine Adjuvants.

  2018cites this paper
• Development and Evaluation of CAF01

  2017cites this paper
• Delta inulin-based adjuvants promote the generation of polyfunctional CD4+ T cell responses and protection against Mycobacterium tuberculosis infection

  2017cites this paper
• Pathogen‐mimicking vaccine delivery system designed with a bioactive polymer (inulin acetate) for robust humoral and cellular immune responses

  2017cites this paper
• Systematic Investigation of the Role of Surfactant Composition and Choice of oil: Design of a Nanoemulsion-Based Adjuvant Inducing Concomitant Humoral and CD4+ T-Cell Responses

  2017cites this paper
• Low Antigen Dose in Adjuvant-Based Vaccination Selectively Induces CD4 T Cells with Enhanced Functional Avidity and Protective Efficacy

  2017cites this paper
• Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model

  2017cites this paper
• Towards an evidence based approach for the development of adjuvanted vaccines.

  2017cites this paper
• CYTOKINE-SECRETORY ACTIVITY OF T-LYMPHOCYTES-HELPERS 17 AND T-LYMPHOCYTES-HELPERS 1 / T-LYMPHOCYTES-HELPERS 17 IN PULMONARY TUBERCULOSIS

  2017cites this paper
• Microcontainers for oral vaccine delivery

  2017cites this paper
• A subunit vaccine based on rH-NS induces protection against Mycobacterium tuberculosis infection by inducing the Th1 immune response and activating macrophages.

  2016cites this paper
• Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?

  2016cites this paper
• Comparative Systems Analyses Reveal Molecular Signatures of Clinically tested Vaccine Adjuvants

  2016cites this paper
• Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators

  2016cites this paper
• Vaccination in early life: standing up to the challenges.

  2016influential citation
• Lipid-Based Nanoparticles for Vaccine Applications

  2016cites this paper
• Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization

  2016cites this paper
• A high ratio of IC31® adjuvant to antigen is necessary for H4 TB vaccine immunomodulation

  2015cites this paper
• Novel Injectable Pentablock Copolymer Based Thermoresponsive Hydrogels for Sustained Release Vaccines

  2015cites this paper
• Characterizing the Association Between Antigens and Adjuvants

  2015cites this paper
• The Application of Liposomes as Vaccine Adjuvants

  2015cites this paper
• Impact of implant composition of twin-screw extruded lipid implants on the release behavior.

  2015cites this paper
• Long-term persistence of immunity induced by OVA-coupled gas-filled microbubble vaccination partially protects mice against infection by OVA-expressing Listeria.

  2015cites this paper
• Intranasal vaccination with killed Leishmania amazonensis promastigotes antigen (LaAg) associated with CAF01 adjuvant induces partial protection in BALB/c mice challenged with Leishmania (infantum) chagasi.

  2015cites this paper
• Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems.

  2015cites this paper
• Transcriptional profile in afferent lymph cells following vaccination with liposomes incorporating CpG

  2015cites this paper
• Elucidating the mechanisms of protein antigen adsorption to the CAF/NAF liposomal vaccine adjuvant systems: effect of charge, fluidity and antigen-to-lipid ratio.

  2014cites this paper
• In vivo investigation of twin-screw extruded lipid implants for vaccine delivery.

  2014cites this paper
• Liposomes as vaccine delivery systems: a review of the recent advances

  2014cites this paper
• Biomaterials for Nanoparticle Vaccine Delivery Systems

  2014cites this paper
• The in vivo expressed Mycobacterium tuberculosis (IVE-TB) antigen Rv2034 induces CD4⁺ T-cells that protect against pulmonary infection in HLA-DR transgenic mice and guinea pigs.

  2014cites this paper
• Combatting infectious diseases; nanotechnology as a platform for rational vaccine design.

  2014cites this paper
• Nanotechnology for the delivery of vaccines

  2014cites this paper
• Enhancement of Adaptive Immunity by the Human Vaccine Adjuvant AS01 Depends on Activated Dendritic Cells

  2014cites this paper
• Chitosan-Based Adjuvants

  2014cites this paper
• A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human.

  2014cites this paper
• Effect of incorporating cholesterol into DDA:TDB liposomal adjuvants on bilayer properties, biodistribution, and immune responses.

  2014cites this paper
• Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl‐sn‐glycero‐3‐phosphocholine content in liposomal adjuvants

  2013cites this paper
• Vaccination with a Fusion Protein That Introduces HIV-1 Gag Antigen into a Multitrimer CD40L Construct Results in Enhanced CD8+ T Cell Responses and Protection from Viral Challenge by Vaccinia-Gag

  2013cites this paper
• TLR2-targeted secreted proteins from Mycobacterium tuberculosis are protective as powdered pulmonary vaccines.

  2013cites this paper
• Potential use of inflammation and early immunological event biomarkers in assessing vaccine safety.

  2013cites this paper
• The physical stability of the recombinant tuberculosis fusion antigens h1 and h56.

  2013cites this paper
• Kinetics of the inflammatory response following intramuscular injection of aluminum adjuvant.

  2013cites this paper
• Do we know the Th1/Th2/Th17 determinants of vaccine response?

  2012cites this paper
• A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog.

  2012cites this paper
• INDUCTION OF STRONGER AND LONG LASTING VACCINE IMMUNITY TO TUBERCULOSIS

  2012cites this paper
• Immune regulation and modulation of allergy and inflammatory diseases

  2012cites this paper
• Protein Antigen Adsorption to the DDA/TDB Liposomal Adjuvant: Effect on Protein Structure, Stability, and Liposome Physicochemical Characteristics

  2012cites this paper